Evidence-Based Medicine Guidelines
Febuxostat for hyperuricaemia in chronic gout
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Febuxostat for Hyperuricaemia in Chronic Gout." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/457721/all/Febuxostat_for_hyperuricaemia_in_chronic_gout.
Febuxostat for hyperuricaemia in chronic gout. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/457721/all/Febuxostat_for_hyperuricaemia_in_chronic_gout. Accessed October 9, 2024.
Febuxostat for hyperuricaemia in chronic gout. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/457721/all/Febuxostat_for_hyperuricaemia_in_chronic_gout
Febuxostat for Hyperuricaemia in Chronic Gout [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 October 09]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/457721/all/Febuxostat_for_hyperuricaemia_in_chronic_gout.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Febuxostat for hyperuricaemia in chronic gout
ID - 457721
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/457721/all/Febuxostat_for_hyperuricaemia_in_chronic_gout
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
